Edward Penhoet

Edward Penhoet

Direktor/Vorstandsmitglied bei Alta BioPharma Management II LLC

83 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Edward E.
Penhoet
founded Chiron Corp.
in 1981, where he worked as Vice Chairman from 1981 to 2001 and Renovis, Inc. in 2000, where he worked as Director from 2000 to 2008.
Dr. Penhoet also currently works at Alta BioPharma Management II LLC, as Managing Director & Director from 2014, Alta BioPharma Management III LLC, as Director, UCSF Benioff Children's Hospital Oakland, as Director, Innovative Genomics Institute, as Director, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member-National Academies from 2014, and President's Council of Advisors on Science & Technology, as Member.
Dr. Penhoet also formerly worked at California Institute for Regenerative Medicine, as Vice Chairman from 2004 to 2008, Immune Design Corp., as Chairman from 2013 to 2019, Alta Partners Management Co. LP, as Director, ZymoGenetics, Inc., as Director from 2000 to 2010, Corcept Therapeutics, Inc., as Director from 2008 to 2010, CymaBay Therapeutics, Inc., as Independent Director from 2013 to 2015, Chimerix, Inc., as Director, Oldtech, Inc., as Director, ChemoCentryx, Inc., as Independent Director from 2011 to 2013, aTyr Pharma, Inc., as Director from 2014 to 2015, Veloxis Pharmaceuticals A, as Independent Director from 2011 to 2013, SCYNEXIS, Inc., as Independent Director from 2014 to 2015, Innate Pharma SA, as Director, IDM Pharma, Inc., as Director from 2007 to 2009, Alta Partners Management VIII LLC, as Director from 2000 to 2016, Bay Area Council Economic Institute, as Director, the University of California, Berkeley, as Professor from 1998 to 2002, and Gordon & Betty Moore Foundation, as President from 2004 to 2008.
Dr. Penhoet received his undergraduate degree in 1963 from Stanford University and doctorate degree in 1968 from the University of Washington.

Aktive Positionen von Edward Penhoet

UnternehmenPositionBeginn
Corporate Officer/Principal 27.07.2009
President's Council of Advisors on Science & Technology Corporate Officer/Principal 18.10.2011
Corporate Officer/Principal 18.10.2011
Alta BioPharma Management II LLC Direktor/Vorstandsmitglied -
Alta BioPharma Management III LLC Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Innovative Genomics Institute Direktor/Vorstandsmitglied -
Alle aktiven Positionen von Edward Penhoet

Ehemalige bekannte Positionen von Edward Penhoet

UnternehmenPositionEnde
IMMUNE DESIGN CORP Vorsitzender 02.04.2019
Alta Partners Management VIII LLC Direktor/Vorstandsmitglied 01.12.2016
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Edward Penhoet im Detail an

Ausbildung von Edward Penhoet

Stanford University Undergraduate Degree
University of Washington Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Edward Penhoet im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
CORCEPT THERAPEUTICS INCORPORATED

Health Technology

CHIMERIX, INC.

Health Technology

ATYR PHARMA, INC.

Health Technology

SCYNEXIS, INC.

Health Technology

INNATE PHARMA

Health Technology

Private Unternehmen21

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Alta BioPharma Management II LLC

Alta BioPharma Management III LLC

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Alta Partners Management VIII LLC

California Institute for Regenerative Medicine

Government

President's Council of Advisors on Science & Technology

Government

Commercial Services

Health Technology

Innovative Genomics Institute

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Edward Penhoet